NAVIGATING THE EVIDENCE FOR EXTRAFINE TRIPLE FORMULATION IN COPD
Thursday, 11 November 2021, 17:00 - 18:00 (Japan Time, UTC+9)
Dr John Blakey (Australia)
Sponsors: Chiesi, Orient EuroPharma
OUTLINE
This webinar provides a space for respiratory health professionals from around the globe to share their experiences. Participants have the chance to ask questions, discuss, and hear perspectives from the speaker.
FORMAT
Welcome message from the APSR President
Welcome message from the Sponsor
Presentation
Q&As
Summary and Closing
(total: 60 minutes)
TOPICS
"Navigating the evidence for extrafine triple formulation in COPD" - Dr John Blakey (Australia)
SPEAKERS
Dr Yoichi Nakanishi
President of the APSR
WELCOME MESSAGE
Dr. Chin Kook Rhee
Head-Elect of APSR COPD Assembly
CHAIR
Dr James Micevski
Medical Director of CHIESI, Australia
SPONSOR REPRESENTATIVE
Dr John Blakey (Australia)
Respiratory Physician Consultant and lead for Asthma at Sir Charles Gairdner Hospital, Perth WA. Adjunct Clinical Associate Professor at Curtin Medical School in Perth, WA.